Abnormal haemorheology, endothelial function and thrombogenesis in relation to hypertension in acute (ictus < 12 h) stroke patients: The West Birmingham stroke project

Blood Coagulation and Fibrinolysis

Volumn 12, Issue 4, 2001, Pages 307-315

  Lip, G Y H ^a   Blann, A D ^a   Farooqi, I S ^a   Zarifis, J ^a   Sagar, G ^a   Beevers, D G ^a  

^a UNIVERSITY DEPARTMENT OF MEDICINE   (United Kingdom)

Author keywords

Blood pressure; Endothelial function; Haemorheology; Stroke; Thrombogenesis

Indexed keywords

D DIMER; FIBRINOGEN; PADGEM PROTEIN; PLASMINOGEN ACTIVATOR INHIBITOR; VON WILLEBRAND FACTOR;

ADULT; AGED; ARTICLE; BLOOD PRESSURE MONITORING; BLOOD RHEOLOGY; CONTROLLED STUDY; ENDOTHELIUM; FEMALE; HEART INFARCTION; HUMAN; HYPERCOAGULABILITY; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; PLASMA VISCOSITY; PRIORITY JOURNAL; STROKE; THROMBOCYTE ACTIVATION; THROMBOGENESIS;

EID: 0034967837     PISSN: 09575235     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001721-200106000-00012     Document Type: Article

References (28)

1. The role of rheology and haemostatic factors in hypertension
2. Does hypertension confer a hypercoagulable state?
3. The effect of antihypertensive drugs on in vivo platelet activity in essential hypertension
4. Relationship of endothelium, thrombogenesis, and haemorheology in systemic hypertension to ethnicity and left ventricular hypertrophy
5. Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: Principal results of the Hypertension Optimal Treatment (HOT) randomised trial
6. von Willebrand factor: A marker of endothelial dysfunction in vascular disorder?
7. von Willebrand factor in plasma: A novel risk factor for recurrent myocardial infarction and death
8. von Willebrand factor and factor VIIL:C in acute cerebrovascular disease
9. von Willebrand factor and soluble E-selectin in hypertension: Influence of treatment and value in predicting the progression of atherosclerosis
10. von Willebrand factor, P-selectin and fibrinogen levels in patients with acute ischaemic and haemorrhagic stroke, and their relationship with stroke subtype and functional outcome
11. Changes in von Willebrand factor and antithrombin III levels in acute stroke: Difference between thrombotic and haemorrhagic stroke
12. Fibrin D-dimer: A useful clinical marker of thrombogenesis?
13. Fibrin D-dimer, von Willebrand factor and tissue plasminogen activator antigens are predictors of major ischaemic heart disease: The Caerphilly study
14. Fibrinogen and risk of cardiovascular disease. The Framingham Study
15. Fibrinogen as a risk factor for stroke and myocardial infarction
16. Fibrinogen and lipid concentrations as risk factors for transient ischaemic attacks and minor ischaemic strokes
17. Analysis of risk factors for stroke in a cohort of men born in 1913
18. Chronic blood hypeviscosity in subjects with acute stroke, transient ischaemic attack, and risk factors for stroke
19. Blood viscosity and fibrinogen concentration following cerebral infarction
20. Plasma fibrinogen levels in stroke
21. Plasma fibrinogen and platelet count in stroke
22. Hematologic abnormalities occur in both cortical and lacunar infarction
23. Blood rheology in arterial disease
24. Is soluble P-selectin a new marker of platelet activation?
25. von Willebrand factor, soluble P-selectin, tissue plasminogen activator and plasminogen activator inhibitor in atherosclerosis
26. Increased soluble P-selectin following myocardial infarction: A new marker for the progression of atherosclerosis
27. Low dose aspirin does not lower in vivo platelet activation in healthy smokers